ResultsMoneycontrol
Torrent Pharma Standalone September 2026 Net Sales at Rs 4,145.00 crore, up 50.07% Y-o-Y
Neutral0
GreyOak summary
Torrent Pharma reported standalone net sales of Rs 4,145 crore for September 2026, a 50.07% year-on-year increase. EBITDA rose 49.28% to Rs 1,560 crore, while EPS decreased to Rs 13.09.
What it affects
- Torrent PharmaceuticalsTORNTPHARMNeutral 0
Sales up 50%, profit down 16.58%.Rolling sentiment Neutral +6
Source
Read the original at MoneycontrolMore Torrent Pharmaceuticals news
- Torrent Pharma Consolidated September 2026 Net Sales at Rs 4,979.00 crore, up 50.79% Y-o-YMoneycontrol · Results ·